Medical Dosimetry
Volume 33, Issue 1 , Pages 6-13 , Spring 2008

Assessment and Minimization of Contralateral Breast Dose for Conventional and Intensity Modulated Breast Radiotherapy

Presented at the 47th Annual Meeting of the American Association of Physicists in Medicine, Seattle, July, 2005.

References 

  1. Arriagada R, Le MG, Rochard F, et al. Conservative treatment versus mastectomy in early breast cancer: Patterns of failure with 15 years of follow-up data. J. Clin. Oncol. 1996;14:1558–1564
  2. Fisher B, Anderson S, Redmond CK, et al. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N. Engl. J. Med. 1995;333:1456–1461
  3. Jacobson JA, Danforth DN, Cowan KH, et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N. Engl. J. Med. 1995;332:907–911
  4. Veronesi U, Salvadori B, Luini A, et al. Breast conservation is a safe method in patients with small cancer of the breast (Long-term results of three randomised trials on 1,973 patients). Eur. J. Cancer. 1995;31A:1567–1569
  5. van Dongen JA, Voogd AC, Fentiman IS, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J. Natl. Cancer Inst. 2000;92:1143–1150
  6. Harvey EB, Brinton LA. Second cancer following cancer of the breast in Connecticut, 1935–82. Natl. Cancer Inst. Monogr. 1985;68:99–112
  7. Kurtz JM, Almaric R, Brandone H, et al. Contralateral breast cancer and other second malignancies in patients treated by breast-conserving therapy with radiation. Int. J. Radiat. Oncol. Biol. Phys. 1988;15:277–284
  8. Obedian E, Fischer DB, Haffty BG. Second malignancies after treatment of early-stage breast cancer: Lumpectomy and radiation therapy versus mastectomy. J. Clin. Oncol. 2000;18:2406–2412
  9. Gao X, Fisher SG, Emami B. Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: A population-based study. Int. J. Radiat. Oncol. Biol. Phys. 2003;56:1038–1045
  10. Horn PL, Thompson WD. Risk of contralateral breast cancer: Assocations with histologic, clinical, and therapeutic factors. Cancer. 1988;62:412–424
  11. Boice JD, Harvey EB, Blettner M, et al. Cancer in the contralateral breast after radiotherapy for breast cancer. N. Engl. J. Med. 1992;326:781–785
  12. Julien JP, Bijkerr N, Fentiman IS, et al. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: First results of the EORTC randomized phase III trial 10853. Lancet. 2000;355:528–533
  13. Unnithan J, Macklis RM. Contralateral breast cancer risk. Radiother. Oncol. 2001;60:239–246
  14. Fraass BA, Roberson PL, Lichter AS. Dose to the contralateral breast due to primary breast irradiation. Int. J. Radiat. Oncol. Biol. Phys. 1985;11:485–497
  15. Muller-Runkel R, Kalokhe UP. Scatter dose from tangential breast irradation to the uninvolved breast. Radiology. 1990;175:873–876
  16. Kelly CA, Wang X-Y, Chu JCH, et al. Dose to contralateral breast: A comparison of four primary breast irradiation techniques. Int. J. Radiat. Oncol. Biol. Phys. 1996;34:727–732
  17. Epstein RJ, Kelly SA, Cook M, et al. Active minimisation of radiation scatter during breast radiotherapy: Management implications for young patients with good-prognosis primary neoplasms. Radiother. Oncol. 1996;40:69–74
  18. Sohn JW, Macklis R, Suh JH, et al. A mobile shield to reduce scatter radiation to the contralateral breast during radiotherapy for breast cancer: Preclinical results. Int. J. Radiat. Oncol. Biol. Phys. 1999;43:1037–1041
  19. Goffman TE, Miller M, Laronga C, et al. Shielding of the contralateral breast during tangential irradiation. Am. J. Clin. Oncol. 2004;27:436–439
  20. Chang SX, Duchesne KM, Cullip TJ, et al. A comparison of different intensity modulation treatment techniques for tangential breast irradiation. Int. J. Radiat. Oncol. Biol. Phys. 1999;45:1305–1314
  21. De La Torre N, Figueroa CT, Martinez K, et al. A comparative study of surface dose and dose distribution for intact breast following irradiation with field-in-field technique vs. the use of conventional wedges. Med. Dosim. 2004;29:109–114
  22. Cavey ML, Bayouth JE, Endres EJ, et al. Dosimetric comparison of conventional and forward-planned intensity-modulated techniques for comprehensive locoregional irradiation of post-mastectomy left breast cancers. Med. Dosim. 2005;30:107–116
  23. Hong L, Hunt M, Chui C, et al. Intensity-modulated tangential beam irradiation of the intact breast. Int. J. Radiat. Oncol. Biol. Phys. 1999;44:1155–1164
  24. Bhatnagar AK, Brandner E, Sonnik D, et al. Intensity-modulated radiation therapy (IMRT) reduces the dose to the contralateral breast when compared to conventional tangential fields for primary breast irradiation: Initial report. Cancer J. 2004;10:381–385
  25. Ruck WR. Characterization of TLD-100 Powder Capsules for Patient Dosimetry. [Masters thesis] Detroit, MI: Wayne State University; 1997;

PII: S0958-3947(07)00080-5

doi: 10.1016/j.meddos.2007.04.003

Medical Dosimetry
Volume 33, Issue 1 , Pages 6-13 , Spring 2008

Article Tools

* Image Usage & Resolution